Granules India Ltd (BOM:532482)
₹ 872.45 +34.25 (+4.09%) Market Cap: 216.19 Bil Enterprise Value: 221.98 Bil PE Ratio: 32.41 PB Ratio: 4.25 GF Score: 74/100

Q3 2026 Granules India Ltd Earnings Call Transcript

Jan 23, 2026 / 12:30 PM GMT
Release Date Price: ₹564.95 (-1.09%)

Key Points

Positve
  • Granules India Ltd (BOM:532482) reported a strong Q3 FY26 with a 22% year-on-year revenue growth, reaching INR 13,879 million.
  • EBITDA increased by 34% compared to the same period last year, indicating improved operational efficiency.
  • The company achieved significant regulatory milestones, including a post-warning letter meeting with the FDA and receiving GMP certification from Brazil.
  • Granules India Ltd (BOM:532482) made progress in its R&D pipeline, with multiple product approvals and filings across various markets.
  • The company demonstrated a commitment to sustainability, improving its CDP climate change rating to 'A' and increasing its S&P CSA score.
Negative
  • The CDMO business experienced a temporary loss, impacting overall financial performance.
  • There were five observations from a recent US FDA inspection, although none related to data integrity.
  • High operating costs were incurred due to planned maintenance activities and additional shifts, affecting short-term profitability.
  • The company is still awaiting formal feedback from the FDA regarding the resolution of the warning letter.
  • Price erosion in the paracetamol segment was noted, which could impact future revenue growth.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GRAN.NS - Granules India Ltd
Q3 2026 Granules India Ltd Earnings Call
Jan 23, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to Granules India Limited Q3 and 9.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Month F 526 earning.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
Conference.

--------------------------------------------------------------------------------
Unidentified_2 [4]
--------------------------------------------------------------------------------
Call.

-------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot